STOCK TITAN
  1. Home
  2. News
  3. HIMS

Hims & Hers Health Inc - HIMS STOCK NEWS

Welcome to our dedicated page for Hims & Hers Health news (Ticker: HIMS), a resource for investors and traders seeking the latest updates and insights on Hims & Hers Health stock.

Hims & Hers Health, Inc. (HIMS) is a cutting-edge telehealth company, headquartered in San Francisco, California, that revolutionizes the way people access healthcare. Founded in 2013, the company provides a multi-specialty platform connecting consumers to licensed healthcare professionals, offering a seamless path to high-quality medical care for various conditions.

Hims & Hers Health, Inc. specializes in a broad range of wellness products and services. Their portfolio includes treatments for hair loss, sexual wellness products, skincare lines, and oral care solutions. The company also diversifies its offerings through an exclusive range of men's fashion items including sweaters, jackets, corduroy, sport coats, wool overcoats, leather boots, flannel shirts, caps, and candles. All products are conveniently available for purchase through their online platform.

The telehealth services provided by Hims & Hers are comprehensive, covering mental health, sexual health, dermatology, primary care, and more. This robust platform ensures consumers receive professional medical consultations from the comfort of their homes.

Hims & Hers Health, Inc. continues to innovate and expand its services to meet the evolving needs of its customers. Recent achievements include advancements in their telehealth technology, expanding partnerships with renowned medical professionals, and enhancing their product lines. The company is financially sound and continues to grow, reflecting positive market performance and consumer trust.

For the latest updates, financial reports, and company news, Hims & Hers Health remains a significant player in both the wellness product market and the telehealth industry.

News

Hims & Hers Health, Inc. Announces $50 Million Share Repurchase Program Authorization

Rhea-AI Summary
Hims & Hers Health, Inc. announces a share repurchase program of up to $50 million of outstanding Class A common stock over the next two years. The program will be used to repurchase shares on a discretionary basis. The decision is driven by the Company's strong business performance and belief that its shares are trading below their intrinsic value. In the third quarter of 2023, revenue was up 57% YoY to $226.7 million, and the Company surpassed 1.4 million subscribers. Full-year revenue is expected to be between $868 and $873 million, up 65% to 66% YoY.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.99%
Tags
buyback
-
News

Hims & Hers Health, Inc. Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Outlook

Rhea-AI Summary
Hims & Hers Health, Inc. reported strong financial results for Q3 2023, with revenue of $226.7 million, up 57% YoY, and a net loss of $7.6 million. The company achieved adjusted EBITDA profitability of $12.3 million. Subscribers grew to 1.4 million, up 56% YoY. Hims & Hers raised its full-year 2023 revenue guidance to a range of $868 million to $873 million and adjusted EBITDA guidance to a range of $43 million to $46 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.99%
Tags
earnings
-
News

Hims & Hers Introduces MedMatch, The Next Generation of Intelligent Diagnostic Services

Rhea-AI Summary
Hims & Hers introduces MedMatch, a technology that uses AI and machine learning to deliver personalized healthcare solutions. Currently in Beta, MedMatch identifies treatments in real-time based on a patient's unique needs. It aims to bridge the gap between need and access in mental health care. MedMatch is being evaluated on metrics like remission rates and patient satisfaction.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.09%
Tags
none
News

Hims & Hers Names Khobi Brooklyn As Chief Communications Officer

Rhea-AI Summary
Hims & Hers appoints Khobi Brooklyn as Chief Communications Officer to strengthen the brand and increase awareness
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.31%
Tags
none
-
News

Hims & Hers to Announce Third Quarter 2023 Financial Results on November 6, 2023

Rhea-AI Summary
Hims & Hers Health to report Q3 2023 financial results
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.48%
Tags
earnings
-
News

Hims & Hers Health, Inc. Reports Second Quarter 2023 Financial Results and Raises Full Year 2023 Outlook

Rhea-AI Summary
Hims & Hers reports Q2 2023 revenue of $207.9 million, up 83% YoY. Net loss of $7.2 million; Adjusted EBITDA profitability of $10.6 million. Subscribers grew to 1.3 million, up 74% YoY. Raises full year 2023 revenue guidance to $830M-$850M and Adjusted EBITDA guidance to $35M-$40M.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.82%
Tags
earnings
News

Hims & Hers Expands Into Cardiovascular Health with New Dual-Action Capabilities

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.82%
Tags
none
-
News

Hims & Hers to Announce Second Quarter 2023 Financial Results on August 7, 2023

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.97%
Tags
earnings
-
News

Half of Women Experience Hair Loss; Hers Unveils Innovative Line of Personalized Solutions

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.56%
Tags
none
News

Laudio Announces $13 Million Series B for its AI Solution that Drives Productivity and Reduces Burnout in Health Systems

Rhea-AI Summary
Laudio, the healthcare management solution, has raised $13 million in a Series B funding round led by Define Ventures. The funding brings Laudio's total funding to $25 million and highlights the growing demand for solutions that increase labor productivity and address burnout in frontline workers. The company plans to invest in platform development, scaling growth, and expanding its sales and marketing efforts.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.11%
Tags
AI

FAQ

What is the current stock price of Hims & Hers Health (HIMS)?

The current stock price of Hims & Hers Health (HIMS) is $49.28 as of February 21, 2025.

What is the market cap of Hims & Hers Health (HIMS)?

The market cap of Hims & Hers Health (HIMS) is approximately 14.5B.

What does Hims & Hers Health, Inc. do?

Hims & Hers Health, Inc. is a telehealth company offering wellness products and connecting consumers to licensed healthcare professionals for various medical conditions.

Where is Hims & Hers Health, Inc. based?

The company is based in San Francisco, California.

When was Hims & Hers Health, Inc. founded?

The company was founded in 2013.

What types of products does Hims & Hers offer?

Hims & Hers offers hair loss prevention medicines, sexual wellness products, skincare products, oral care solutions, as well as men's fashion items like sweaters, jackets, and leather boots.

What medical services are available through Hims & Hers?

The company provides telehealth services covering mental health, sexual health, dermatology, primary care, and more.

How can I purchase products from Hims & Hers?

Products are available for purchase online through their platform.

How is Hims & Hers Health, Inc. performing financially?

Hims & Hers Health, Inc. is financially sound and continues to grow, reflecting positive market performance.

What recent achievements has Hims & Hers Health, Inc. made?

Recent achievements include advancements in telehealth technology, expanding partnerships with medical professionals, and enhancing product lines.

Does Hims & Hers collaborate with healthcare professionals?

Yes, Hims & Hers connects consumers with licensed healthcare professionals for consultations and medical care.

What makes Hims & Hers Health, Inc. unique?

Hims & Hers combines a broad range of wellness products with comprehensive telehealth services, enabling convenient access to high-quality medical care from home.
Stock HIMS logo
Hims & Hers Health Inc

NYSE:HIMS

HIMS Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

HIMS Stock Data

14.51B
183.87M
11.44%
64.42%
25.9%
Household & Personal Products
Services-offices & Clinics of Doctors of Medicine
Link
United States
SAN FRANCISCO